+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Lung Adenocarcinoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Lung Adenocarcinoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sick sinus syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Sick sinus syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ventricular Fibrillation - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ventricular Fibrillation - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Whooping cough/Pertussis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Whooping cough/Pertussis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Pulmonary Sarcoidosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Sarcoidosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Lung Fibrosis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Lung Fibrosis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Malignant Pleural Effusion - Epidemiology Forecast to 2032 - Product Thumbnail Image

Malignant Pleural Effusion - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Meconium Aspiration Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Meconium Aspiration Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cystic fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cystic fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type and End User - Product Thumbnail Image

Americas Sleep Apnea Market Forecast to 2030 - Regional Analysis By Type and End User

  • Report
  • August 2023
  • 136 Pages
  • North America, Latin America North America, Latin America
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more